Evidence map›Paper›PMID 36200514›Full record

ArticleChemistryOpen2022

Antiproliferative Activity of (-)-Isopulegol-based 1,3-Oxazine, 1,3-Thiazine and 2,4-Diaminopyrimidine Derivatives.

Fatima Z Bamou, Tam M Le, Bizhar A Tayeb, Seyyed A S Tahaei, Renáta Minorics, István Zupkó, Zsolt Szakonyi

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Stereoselective Synthesis and Antimicrobial Studies ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fatima Z BamouInstitute of Pharmaceutical Chemistry and, MTA-SZTE Stereochemistry Research Group, Hungarian Academy of Sciences, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.
Tam M LeInstitute of Pharmaceutical Chemistry and, MTA-SZTE Stereochemistry Research Group, Hungarian Academy of Sciences, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.ORCID 0000-0002-8296-887X
Bizhar A TayebDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.ORCID 0000-0001-5197-564X
Seyyed A S TahaeiDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.
Renáta MinoricsDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.ORCID 0000-0001-9685-813X
István ZupkóDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.ORCID 0000-0003-3243-5300
Zsolt SzakonyiInstitute of Pharmaceutical Chemistry and, MTA-SZTE Stereochemistry Research Group, Hungarian Academy of Sciences, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.ORCID 0000-0003-2432-8409
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel heterocyclic structures, namely 1,3-oxazines, 1,3-thiazines and 2,4-diaminopyrimidines, were designed and synthesised. The bioassay tests demonstrated that, among these analogues, 2,4-diaminopyridine derivatives showed significant antiproliferative activity against different human cancer cell lines (A2780, SiHa, HeLa, MCF-7 and MDA-MB-231). Pyrimidines substituted with N

Indexed as

Ovarian NeoplasmsThiazinesAniline CompoundsCell Line, TumorCell ProliferationCyclohexane MonoterpenesFemaleHumansOxazinesPyrimidines2,4-diaminopyrimidineAniline CompoundsCyclohexane MonoterpenesisopulegolOxazinesPyrimidinesThiazines1,3-oxazines1,3-thiazines2,4-diaminopyrimidines(−)-isopulegol(+)-neoisopulegol

Identifiers

PMID36200514
PMCPMC9535514
OpenAlexW4302292709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.